

Using urine drug testing to support healthy boundaries in clinical care
Abstract
Keywords
References
Gourlay DL, Heit HA: Pain and addiction: Managing risk through comprehensive care. J Addict Dis. 2008; 27(3): 23-30.
Katz N, Fanciullo GJ: Role of urine toxicology testing in the management of chronic opioid therapy. Clin J Pain. 2002; 18(4 Suppl): S76-S82.
Gourlay D, Heit H, Caplan YH: Urine Drug Testing in Clinical Practice: The Art and Science of Patient Care. 5th ed. Baltimore, MD: Johns Hopkins University School of Medicine 2012.
Heit HA, Gourlay DL: Urine drug testing in pain medicine. J Pain Symptom Manage. 2004; 27(3): 260-267.
Gourlay D, Heit HA: The art and science of urine drug testing. Clin J Pain. 2010; 26(4): 358.
Nafziger AN, Bertino JS Jr: Utility and application of urine drug testing in chronic pain management with opioids. Clin J Pain. 2009; 25(1): 73-79.
Federation of State Medical Boards: Model Policy on the Use of Opioid Analgesics in the Treatment of Chronic Pain. July 2013: 1-29. Available at http://www.pcsso.org/sites/default/files/FSMB%20Pain%20Policy%20(July%202013).pdf. Accessed October 27, 2014.
Gourlay DL, Heit HA: Universal precautions revisited: Managing the inherited pain patient. Pain Med. 2009; 10(Suppl 2): S115-S123.
Savage SR: Long-term opioid therapy: Assessment of consequences and risks. J Pain Symptom Manage. 1996; 11(5): 274-286.
Gourlay D, Heit H: Universal precautions: A matter of mutual trust and responsibility. Pain Med. 2006; 7(2): 210-211; author reply 212.
DOI: https://doi.org/10.5055/jom.2015.0247
Refbacks
- There are currently no refbacks.